Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease.

Abstract excerpt

Metabolic dysfunction-associated steatotic liver disease (MASLD) impacts more than a third of adults worldwide. The burgeoning epidemic of MASLD has led to increases in atherosclerotic cardiovascular disease (CVD), which is the leading cause of morbidity and mortality among affected individuals, particularly those with type 2 diabetes. Subsets of patients with MASLD will develop progressive liver disease,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiovascular Diseases
• Share to Diabetes Mellitus, Type 2
• Share to Fatty Liver